Clonidine, an a2-adrenoreceptor agonist, is an anti-glaucoma drug clinically used in many developing countries, and its abuse might damage the cornea and impair human vision. However, its cytotoxicity and precise mechanisms need to be elucidated. Herein, we investigated the cytotoxicity of clonidine and its underlying mechanisms, using an in vitro model of human corneal epithelial (HCEP) cells and an in vivo model of cat corneas, respectively. HCEP cells were treated with various doses of clonidine for 1-28 h, resulting in abnormal morphology, decline of cell viability and G 1 phase arrest in a time-and/ or dose-dependent manner. Moreover, clonidine treatment induced elevation of plasma membrane permeability, phosphatidylserine externalization, DNA fragmentation, and apoptotic body formation in HCEP cells. Furthermore, we found that clonidine treatment resulted in activated caspase-2, -3, -8, and -9, disruption of the mitochondrial transmembrane potential, downregulation of Bcl-2, and upregulation of Bad, cytoplasmic cytochrome c and apoptosis inducing factor, suggesting that clonidine-induced apoptosis is triggered through Fas/TNFR1 death receptors and Bcl-2 family proteins-mediated mitochondria-dependent pathways. Finally, our in vivo results displayed that 0.25% clonidine could induce DNA fragmentation of cat corneal epithelial cells. In summary, our findings suggest that clonidine above 1/32 of its clinical therapeutic dosage is cytotoxic to corneal epithelial cells by inducing cell apoptosis both in vitro and in vivo, and its pro-apoptotic effect on HCEP cells is triggered by a Fas/TNFR1 death receptors-mediated, mitochondria-dependent signaling pathway.
Glaucoma, a common eye disease caused by increased intraocular pressure (IOP), can permanently destroy vision in the affected eye, and has been the second-leading cause of blindness after cataracts worldwide (Kingman, 2004; Casson et al., 2012) . To prevent eye damages from glaucoma, anti-glaucoma eye drops are often the first choice over glaucoma surgery (Diestelhorst, 1996) . Among clinically used anti-glaucoma eye drops, a2-adrenergic agonists are very effective agents because of their dual mechanisms of decreasing aqueous humor production and increasing uveoscleral outflow. Clonidine, an a2-adrenergic agonist, has been frequently used for the treatment of hypertension (with a clinical therapeutic concentration of 0.25%) in eye clinic. Owing to its side effects on corneas such as keratitis and even corneal opacity (Parikh et al., 2008; Pozarowska et al., 2010; Tita et al., 2001) , it has been replaced by new generation of a2-adrenergic agonists, such as apraclonidine and brimonidine, in United States and the other developed countries (Crassous et al., 2007) . However, clonidine is still in use in many developing countries, such as China, India, and most African countries, where lives the largest population of glaucoma sufferers (Quigley, 1996; Weigert et al., 2007) . Therefore, assessment of the cytotoxicity of clonidine and determining its underlying mechanisms will be of great importance for the secure medication of clonidine in eye clinic.
Human corneal epithelium, a well-stratified multilayer cell structure, is a protective barrier of the transparent cornea against foreign toxicants and pathogens. As the corneal epithelium is in direct contact with topical drugs, any acute damage to it from eye drops might lead to the disruption of its barrier function and result in keratitis and blurred vision, whereas the homeostasis of human corneal epithelial (HCEP) cells can be maintained by the proliferation of basal cells of corneal epithelium and corneal limbal stem cells (Loma et al., 2015; West et al., 2015) . Unfortunately, the cytotoxicity of clonidine to human corneal epithelium and its cytotoxic mechanisms remain to be elucidated. Recently, a nontransfected HCEP cell line which has been proven to maintain normal inherent properties along with a normal phenotype in functional HCEP equivalent constructions (Fan et al., 2011; Xu et al., 2012a,b) , was established in our laboratory, and provides an effective in vitro model for toxicological studies of clonidine Shan and Fan, 2016; Tian et al., 2015) . Therefore, to provide new insights into the cytotoxic mechanisms of anti-glaucoma drugs to the cornea and references for their secure medication in eye clinic, the present study was conducted to investigate the cytotoxicity of clonidine to corneal epithelium using an in vitro model of HCEP cells and an in vivo model of cat corneas, and to characterize its toxic mechanisms at both cellular and molecular levels.
MATERIALS AND METHODS
Materials. Clonidine hydrochloride (C 9 H 9 Cl 2 N 3 •HCl; MW: 266.55 Dalton; in powder with a purity > 98.0% was purchased from Tokyo Chemical Industry (Tokyo, Japan). A stock solution of clonidine at a concentration of 0.5% (2-fold of its clinical therapeutic dosage of 0.25%) was prepared by dissolving clonidine powder in serum-free DMEM medium (Invitrogen, Carlsbad, California) . Then the stock solution was double-diluted with DMEM medium with 20% fetal bovine serum (FBS) (Invitrogen) to a final concentration from 0.25% to 0.00390625% in 10% FBS-DMEM just before usage. Human corneal epithelial (HCEP) cells at Passage 78, from an established nontransfected HCEP cell line (ntHCEPC01) (Fan et al., 2011) , were maintained and cultured in 10% FBS-DMEM medium (Invitrogen) at 37 C in 25 cm 2 culture flasks (Nunc, Copenhagen, Denmark).
Animals. Male domestic cats, about 2.5 kg in body weight without eye or corneal disorders, were purchased from the Experimental Animal Centre of Shandong Province (Jinan, China) with a certificate number of SYXK-(SD)-2013-0001. They were maintained in an air-conditioned animal room with a temperature of 22 6 1 C, a relative humidity of 55 6 5%, ventilation frequency of 18 times/h, and a 12-h light/dark cycle. Each of them was housed in isolated stainless steel cages and allowed free access to food and water throughout the acclimation period. All of them were acclimated for 1 week prior to the commencement of the experiment, and their usage in toxicological studies were approved by the institutional Ethics Committee of Animal Care and Experimentation (approval no. SD-SYKY-2014-021). All of animal protocols were in adherence to the guidelines in the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.
Experimental design. The cytotoxic effects of clonidine on the nontransfected HCEP cells were investigated by observing the cell growth, morphology, viability, and cell cycle progression by light microscopy, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-Htetrazolium bromide (MTT) assay, and flow cytometry (FCM) using propidium Iodide (PI) staining, respectively. Then, the pro-apoptotic effect of clonidine was investigated in vitro by determining plasma membrane (PM) permeability, phosphatidylserine (PS) externalization in PM, nuclear DNA fragmentation, chromatin condensation, and apoptotic body formation, by acridine orange/ethidium bromide (AO/EB) double staining, FCM using Annexin V/PI staining, DNA agarose gel electrophoresis and transmission electron microscopy (TEM), respectively. Furthermore, the apoptosis- In vitro culture and treatment. HCEP cells were inoculated into culture flasks or plates (all from Nunc) and cultured in 10% FBS-DMEM medium at 37 C. Once the cells grew into the logarithmic phase (about 60-70% confluence), the culture medium of the cells was replaced entirely with the medium containing clonidine at concentrations ranging from 0.00390625% to 0.25%, respectively. HCEP cells cultured in the same medium containing no clonidine at the same time point were used as blank controls in all experiments.
Morphological observations of HCEP cells. The morphology and growth status of HCEP cells were monitored by inverted light microscopy. HCEP cells were inoculated into a 24-well culture plate and cultured in 10% FBS-DMEM medium at 37 C, 5% CO 2 .
Once the cells reached logarithmic phase, the old medium in each well was replaced completely with medium containing clonidine at different concentrations as described above. The cells were cultured under the same condition as described above, and their morphology and growth status were successively monitored with a TS100 inverted microscope (Nikon, Tokyo, Japan) every 1-4 h.
MTT assay of HCEP cells. The cell viability of HCEP cells was measured by MTT assay as previously described (Shan and Fan, 2016) . Briefly, HCEP cells were inoculated into a 96-well plate at a density of 1 Â 10 4 cells per well, and were cultured and treated with clonidine as described. At an interval of 1-4 h, 20 ll of 5 mg/ ml MTT (Sigma-Aldrich, St. Louis, Missouri) was added into each well and incubated at 37 C in dark for 4 h. After the MTTcontaining medium was discarded with great caution, 150 ll of dimethyl sulfoxide (DMSO; Sigma-Aldrich) was added to dissolve the generated formazan, and then the 490 nm absorbance of each well was measured with a Multiskan GO microplate reader (Thermo Scientific, Massachusetts). The IC 50 value of clonidine was calculated based on the cell viability of HCEP cells in the monitoring period of 28 h.
AO/EB double-staining of HCEP cells. Plasma membrane permeability of HCEP cells was measured by AO/EB double-staining following the method reported previously (Li et al., 2015) . In brief, HCEP cells in a 24-well plate were cultured and treated with clonidine as described above. The cells were harvested by trypsinization and centrifugation as described previously (Fan et al., 2011) . After stained with 100 lg/ml AO/EB (1:1) solution (Sigma-Aldrich) for 1 min, the cell suspension was observed under a Nikon Ti-S fluorescent microscope. HCEP cells with red or orange nuclei were counted as apoptotic cells while those with green nuclei as nonapoptotic cells, and the apoptotic ratio was calculated according to the formula: "Apoptotic rate (%) ¼ Apoptotic cells/(Apoptotic cells þ nonapoptotic cells) Â100" with at least 300 cells counted in each group from 3 parallel samples.
DNA agarose gel electrophoresis of HCEP cells. DNA fragmentation of HCEP cells was examined by agarose gel electrophoresis as described previously (Li et al., 2015) . Briefly, the cells were cultured in 25 cm 2 flasks, treated with clonidine and harvested as described above. After the cells were washed with ice-cold phosphate-buffered saline (PBS) by centrifugation (200 Â g, 10 min), their DNA was isolated with a Quick Tissue/Culture Cells Genomic DNA Extraction Kit (ComWin Biotechnology, Beijing, China) following the manufacturer's instructions. The DNA extracts from each group was electrophoresed in a 1% agarose gel (200 mA, 260 min), stained with 0.5 lg/ml EB solution for 10 min, and observed with an UVP EC3 imaging system (LLC Upland, California).
TEM observation of HCEP cells. The ultrastructure of HCEP cells was visualized by TEM following the method described previously (Tian et al., 2015) . In brief, the cells in 25 cm 2 flasks were cultured, treated with 0.125% clonidine and harvested at 4, 8, and 12 h, respectively, as described above. After fixed successively with 4% glutaraldehyde and 1% osmium tetroxide, the cells were dehydrated and embedded in epoxy resin. Ultrathin sections were stained with 2% uranyl acetate/lead citrate and observed under a H700 transmission electron microscope (Hitachi, Tokyo, Japan).
FCM analysis of HCEP cells. The cell cycle progression, PS orientation in PM and MTP of HCEP cells were detected and analyzed by FCM as reported previously (Shan and Fan, 2016) . Briefly, the cells in 6-well plates were cultured, treated with 0.125% clonidine, and harvested at 4, 8, and 12 h as described above, respectively, and fixed with 70% alcohol overnight at 4 C. For cell cycle assay, the fixed cells from each group were re-suspended in 500 ll PI and RNase solution (BD Biosciences, San Jose, California), and incubated in dark for 30 min. For PS externalization assay, 5 ll fluorescein isothiocyanate (FITC)-labeled Annexin V and 5 ll PI (BD Biosciences) were added into 500 ll of cell suspension, and incubated in dark for 15 min. For MTP assay, 5 ll of 10 lg/ml JC-1 solution (SigmaAldrich) was added into 500 ll cell suspension, and incubated in dark for 15 min. The stained HCEP cells were assayed with a FC500 MPL flow cytometer (Beckman Coulter, Fullerton, California).
ELISA measurement of activated caspases in HCEP cells. Caspase activation in HCEP cells was measured by ELISA as described previously . In brief, the cells in 6-well plates were cultured, treated with 0.125% clonidine, and harvested every 2 h as described above. Whole-cell protein extracts were prepared using 500 ml RIPA lysis buffer containing phenylmethylsulfonyl fluoride (PMSF) (Biotime Company, Shanghai, China) and coated into a high binding 96-well microtiter plate overnight at 4 C.
Following 3 washes with PBS containing 0.05% Tween-20 (PBST), each well was blocked with 5% nonfat milk (BD Bioscience, New Jersy), incubated with 100 ml of rabbit anti-human caspase-2, -3, -8, and -9 (active form) monoclonal antibodies (1:500; Biosynthesis biotechnology, Beijing, China) at 37 C for 90 min, respectively, and then incubated with horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody (1:3000; ComWin Biotechnology) at 37 C for 120 min. Following 3 washes with PBST, a colorimetric reaction was induced by 1% tetramethylbenzidine for 25 min at room temperature in dark. After color development was stopped with 50 ll of 0.5 M H 2 SO 4 solution, the 490 nm absorbance of each well was measured with a Multiskan GO microplate reader (Thermo Scientific).
Western blot. The expression level of Bcl-2 family proteins and the cytoplasmic amount of mitochondria-released apoptosistriggering proteins in HCEP cells was quantified by Western blot as previously described (Tian et al., 2015) . For short, the cells in 25 cm 2 flasks were treated with 0.125% clonidine and harvested at 4, 8, and 12 h, respectively, as described above. Whole-cell protein extract was prepared as described above for determining the expression of Bcl-2 family proteins, and cytoplasmic extract was prepared using a mitochondrial/cytoplasmic protein extraction kit (Sangon biological engineering, Shanghai, China) for quantitative assay of cytoplasmic pro-apoptotic proteins released from mitochondria. The protein extract from each group was electrophoresed by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene difluoride membranes. After blocked with 5% nonfat milk, the membranes were incubated with rabbit antihuman IgG monoclonal antibody to glyceraldehyde-3-phosphatedehydrogenase (GADPH; 1:10 000), Bcl-2 (1:1000), Bad (1:2000), cytochrome c (Cyt. C; 1:5000), and apoptosis inducing factor (AIF, 1:1000) (all from Abcam, Cambridge, UK), respectively, at 4 C overnight. After incubated 90 min with HRPconjugated goat anti-rabbit IgG monoclonal antibody (1:2000; Abcam) at room temperature, immunoreactive bands of the membranes were visualized using enhanced chemiluminescence reagent (Pierce, Rorkford, Illinois) and X-ray films. The optical density of each band was analyzed with ImageJ 1.48 image analysis software (NIH, New York), GADPH as an internal control.
In vivo detection of cat corneas. The cytotoxic and pro-apoptotic effects of clonidine to corneal epithelial cells were verified by in vivo model of cat corneas using in situ TUNEL assay as reported previously . The corneas of the right eyes frommicroscope and a Nikon E80i fluorescent microscope, respectively.
Statistics. Each experiment in the present study was repeated 3 times independently. All data were presented as "mean 6 SD" and analyzed for statistical significance by one-way ANOVA using SPSS 17.0 software (SPSS, Inc., Chicago, Illinois), and Fisher's least significant difference test was used for post hoc analysis. Differences to blank controls were considered statistically significant when P < .05.
RESULTS

Clonidine Induced Morphological Abnormality of HCEP Cells
To evaluate the cytotoxicity of clonidine, the morphology of clonidine-exposed HCEP cells were examined by light microscopy. Our results showed that HCEP cells exposed to clonidine at a concentration varying from 0.0078125% to 0.25% exhibited dose-and time-dependent growth retardation and cytopathic morphological alterations such as cell shrinkage, detachment from plate bottom. Although no obvious differences were observed between HCEP cells exposed to 0.00390625% clonidine and blank controls (Fig. 1 ). These implied that clonidine above the concentration of 0.0078125% might have a dose-and timedependent cytotoxicity to HCEP cells in vitro, by leading to morphological abnormality and cell growth retardation.
Clonidine Induced Cell Viability Decline of HCEP Cells
To further verify the cytotoxicity of clonidine, the cell viability of clonidine-exposed HCEP cells was examined by MTT assay. We found a decline in HCEP cell viability after exposed to clonidine above the concentration of 0.0078125% (P < .01 or .05) with time. Although the HCEP cells treated with 0.00390625% of clonidine showed no significant differences to blank controls (Fig. 2) . Moreover, the IC 50 value of clonidine on HCEP cells was calculated to be 0.051 6 0.008%. Our findings consistently suggested that clonidine above the concentration of 0.0078125% has a dose-and time-dependent cytotoxicity to HCEP cells in vitro.
Clonidine Induced Cell Cycle Arrest of HCEP Cells
To determine the growth retardation mechanisms of clonidine, the cell cycle progression of clonidine-exposed HCEP cells was examined by FCM using PI staining. After exposure to 0.125% of clonidine for 4, 8, and 12 h, respectively, the number of HCEP cells in G 1 phase increased with time (P < .05 or .01), and that in S and G 2 /M phases decreased with time (P < .01) compared with blank controls (Table 1) . These results suggested that G 1 phase arrest is involved in clonidine-induced growth retardation of HCEP cells.
Clonidine Induced PM Abnormality of HCEP Cells As the underlying mechanisms of clonidine cytotoxicity are potentially associated with cell apoptosis, the PM permeability transition and PS externalization in clonidine-exposed HCEP cells were then detected to determine the pro-apoptotic effects of clonidine, by AO/EB double staining and FCM, respectively. Results of AO/EB double staining showed that clonidine could induce dose-and time-dependent elevation of PM permeability at concentrations above 0.0078125% (P < .01 or .05) when compared with blank controls, and the apoptotic ratios from each group were shown in Figure 3 . Owing to the suitable proapoptotic rate of 0.125% clonidine-exposed HCEP cells, 0.125% of clonidine was used for most of the subsequent investigations in this study. Our results of FCM with Annexin V/PI staining showed that the number of Annexin V-positive cells (PS-externalized cells) increased with time after exposed to 0.125% clonidine for 4, 8, and 12 h (P < .01) ( Table 2 ). All these results indicated that clonidine can induce PM abnormality, including permeability elevation and PS externalization in HCEP cells, implying its pro-apoptotic effects.
Clonidine Induced DNA Fragmentation and Ultrastructural Abnormality of HCEP Cells To further prove the pro-apoptotic effects of clonidine, DNA fragmentation and ultrastructural abnormality of clonidineexposed HCEP cells were also investigated by DNA agarose gel electrophoresis and TEM, respectively. Results of DNA electrophoresis indicated that the genomic DNA extracted from clonidine-exposed HCEP cells was highly fragmented, and typical DNA ladders were found in the cells treated with 0.03125-0.125% clonidine, whereas no DNA ladder was found in the blank controls (Fig. 4A) . Transmission electron microscopy observations revealed that clonidine-exposed HCEP cells exhibited ultrastructure disorganizations, including protrusion lost, cytoplasmic vacuolation, mitochondrial swelling, chromatin condensation, and apoptotic body formation (Fig. 4B) . These results revealed that clonidine exposure also resulted in DNA fragmentation and ultrastructure abnormality such as apoptotic body formation in HCEP cells, proving its pro-apoptotic effects.
Clonidine Induced Caspase Activation of HCEP Cells
To postulate the apoptosis-triggering signaling pathway of clonidine, we further investigated the activation of caspase-2, -3, -8, -9 in clonidine-exposed HCEP cells by ELISA. We found that 0.125% clonidine could activate caspase-2 and -8 from 2 to 8 h (P < .01 or .05), and caspase-3 and -9 from 2 to 10 h (P < .01 or .05) in HCEP cells, respectively. Caspase-2, -8, and -9 were all activated to their peak value at 2 h (P < .01) while caspase-3 was activated to its peak value at 4 h (P < .01) (Fig. 5) . Our results suggested that clonidine can induce apoptosis through the activation of caspase-2, -8, -9, and -3 successively in HCEP cells.
Clonidine Induced MTP Disruption and Alterations of Pro-Apoptotic Proteins in HCEP Cells
To affirm whether a mitochondria-dependent pro-apoptotic signaling pathway was involved in clonidine-induced apoptosis, MTP disruption and quantitative alterations of mitochondriaassociated apoptosis regulators in clonidine-exposed HCEP cells were detected by FCM and Western blot, respectively. Our JC-1 staining FCM results showed that clonidine could also induce MTP disruption in HCEP cells, and the number of JC-1 positive cells (MTP-disrupted cells) increased with time after exposed to 0.125% clonidine for 4, 8, and 12 h (Table 3) . Western blot results displayed that the amount of cytoplasmic Cyt. c and AIF release was up-regulated, and that the expression level of proapoptotic Bad was up-regulated while that of anti-apoptotic Bcl-2 was down-regulated in HCEP cells after exposed to 0.125% clonidine for 4 and 8 h, respectively ( Fig. 6A and B ). All these results indicated that the clonidine can induce apoptosis of HCEP cells through a mitochrodria-dependent pathway, via the disruption of MTP, downregulation of Bcl-2, and upregulation of Bad along with the cytoplasmic amount of Cyt. c and AIF.
Clonidine Induced DNA Fragmentation of CCEP Cells In Vivo To further validate the cytotoxicity and the pro-apoptotic effect of clonidine on corneal epithelial cells, the effects of clonidine on CCEP cells was investigated using an in vivo model of cat corneas. Our results showed that the CCT and IOP of clonidineexposed eyes had no significant difference to control eyes during the monitoring period (Fig. 7A) . Moreover, ex vivo characterizations of cat corneas after exposed to 0.25% clonidine for 40 days displayed that the wing cells along with basal cells in the corneal epithelium of clonidine-exposed cat corneas were TUNEL positive, ie, their nuclear DNA was fragmented (Fig. 7B) . These results indicated that clonidine at its clinical concentration can also induce apoptosis of CCEP cells in vivo.
DISCUSSION
Damages to HCEP cells from toxic eye drops often result in corneal opacification and visual impairment (Whitcher et al., 2001; Fan et al., 2015; Tian et al., 2015) . To provide references for the secure medication of clonidine in eye clinic in many developing countries, the cytotoxic effects and toxic mechanisms of this anti-glaucoma drug on corneal epithelial cells were investigated both in vitro and in vivo in the present study.
To assess the cytotoxicity of clonidine, we first investigated the cell morphology, growth status, and cell viability of each group is expressed as percentage (mean 6 SD) compared with its corresponding blank controls based on 490 nm absorbance (n ¼ 3). *P <.05, **P <.01 versus blank control.
clonidine-exposed HCEP cells in vitro. Our results showed that clonidine at concentrations above 0.0078125% (1/32 of its clinical therapeutic dosage) has a dose-and time-dependent cytotoxicity to HCEP cells by inducing morphological abnormality, growth retardation, and viability decline of HCEP cells.
Moreover, FCM with PI staining displayed that 0.125% clonidine could induce G 1 phase arrest of these cells, implying that cell cycle arrest is involved in the growth retardation induced by clonidine. The dose-and time-dependent cytotoxicity and G 1 phase arrest of HCEP cells induced by clonidine are supported by our previous reports of the other topical ophthalmic drugs Pang and Fan, 2016; Shan and Fan, 2016) . As cellular atrophy, cell viability decline and cell cycle arrest are often related with apoptosis triggered by chemotherapeutic agents (Li et al., 2015; Lobner, 2000; Shan and Fan, 2016; Zhou et al., 2013) , we hypothesized that the cytotoxicity of clonidine to HCEP cells might also be related with induction of cell apoptosis. To prove this hypothesis, we characterized the PM permeability transition, PS externalization, DNA fragmentation, and apoptotic body formation of clonidine-exposed HCEP cells, which are the hallmark features of cell apoptosis (Dallaporta et al., 1999; Fadok et al., 2001; Takemura et al., 2001) . Our results indicated that clonidine-exposed HCEP cells exhibited all of the above apoptotic features, suggesting that clonidine has a proapoptotic effect on these cells in vitro. Therefore, the cytotoxicity of clonidine to HCEP cells is achieved most probably by inducing cell apoptosis. This conclusion is also supported by our previous reports of the other topical ophthalmic drugs Pang and Fan, 2016; Shan and Fan, 2016; Tian et al., 2015) .
Apoptosis is triggered orderly by intricate signaling pathways, in which the extrinsic pathway mediated by death receptors often results in activations of initiator caspase-2, -8, and/or -10, and the intrinsic pathway controlled by mitochondria includes the activation of initiator caspase-9 (Fan et al., 2005; Jin and El-Deiry, 2005) . To reveal the possible pro-apoptotic signaling pathways of clonidine, we further inspected the activation pattern of various caspases in clonidine-exposed HCEP cells in vitro. We found that clonidine can activate caspase-2, -8, -9, and -3 successively in these cells. As caspase-2 and -8 are, respectively, a caspase required for tumor necrosis factor receptor 1 (TNFR1)-and factor-associated suicide (Fas)-mediated extrinsic pro-apoptotic pathway (Wajant, 2002; Fan et al., 2005) , our results of caspase-2, -8, and -9 activation suggested that the clonidine-induced apoptosis of HCEP cells might be triggered via death receptors of TNFR1-and Fas-mediated, mitochondriadependent signaling pathways. The involvement of both extrinsic and intrinsic pro-apoptotic pathways in clonidine-induced HCEP cell apoptosis has also been reported in other chemical induced apoptosis (Sun et al., 1999; Zhang et al., 2013; Fan et al., 2015; Pang and Fan, 2016; Tian et al., 2015; Wen et al., 2015) .
Generally, the regulation of mitochondria-dependent cell apoptosis requires the cooperation of Bcl-2 family proteins and mitochondria-sequestered pro-apoptotic proteins whose release into the cytoplasm is triggered by the disruption of MTP (Adams and Cory, 1998; Brenner and Kroemer, 2000; Mart ınez-F abregas et al., 2014) . To further prove the involvement of mitochondria-dependent pro-apoptotic pathway in the clonidine-induced apoptosis, we finally investigated the disruption of MTP, mitochondrial release of Cyt. c and AIF, and expressional alteration of Bcl-2 family proteins in clonidine-exposed HCEP cells in vitro. Our results displayed that clonidine can also induce the disruption of MTP, upregulation of the expression of Bad as well as the cytoplasmic amount of mitochondriareleased Cyt. c and AIF, and downregulation of Bcl-2 expression in these cells. As demonstrated, the anti-apoptotic Bcl-2 prevents, whereas the pro-apoptotic Bad induces the release of mitochondria-sequestered pro-apoptotic proteins (Adams and Cory, 1998; Siddiqui et al., 2015) , among which Cyt. c is an indispensable activator of caspase-9 and AIF is a unique trigger of caspase-independent large-scale DNA fragmentation (Lü et al., 2003; Hu et al., 2014) . Therefore, our results of MTP disruption, upregulation of cytoplasmic Cyt. c and AIF along with the altered expression of the Bcl-2 family proteins, combined with caspase-9 activation, proved that the clonidine-induced cell apoptosis is triggered by a Bcl-2 family protein-regulated mitochondria-dependent signaling pathway. This conclusion is also endorsed by our previous reports on the apoptosis of HCEP cells triggered by the other topical ophthalmic drugs Pang and Fan, 2016; Shan and Fan, 2016; Tian et al., 2015) . Even the above findings are particularly relevant to proving the cytotoxic and pro-apoptotic effects of clonidine on HCEP cells in vitro, they do not allow us to predict clinical inferences The cells were treated with or without 0.125% clonidine for the indicated time, and the activation of caspase-2, -3, -8, and -9 was measured by ELISA using monoclonal antibodies against their active forms. The 490 nm absorbance of each group was expressed as mean 6 SD (n ¼ 3). *P <.05, **P <.01 versus the blank control. directly without in vivo investigations. To further validate the cytotoxic and pro-apoptotic effects of clonidine, we finally investigated the effects of clonidine on CCEP cells using an in vivo model of cat corneas. We found that clonidine at its clinical concentration of 0.25% could induce DNA fragmentation in the wing cells and basal cells of cat corneal epithelium in vivo. The basal distribution of DNA-fragmented cells in cat corneal epithelium could be explained by the active dividing abilities of basal cells and wing cells which are much more sensitive to chemicals and drugs (Kovar ıkov a et al., 2004) . There is no significant difference of CCT between clonidine-exposed corneas and blank controls, which might be explained by the homeostasis of corneal epithelium maintained by limbal epithelial stem cells (LESCs). As DNA fragmentation is often related with apoptosis (Doonan and Cotter, 2013) , our results suggested that clonidine might also be cytotoxic to CCEP cells in vivo by inducing cell apoptosis. To our knowledge, this is the first report of the cytotoxicity and toxic mechanisms of clonidine to corneal epithelial cells both in vitro and in vivo. Although these findings may not be exactly the same as in clinical situations, they are particularly relevant in deciding the optimal dosage of the anti-glaucoma drug to be safely applied in eye clinic.
In conclusion, clonidine above 1/32 of its clinical therapeutic concentration has a dose-and time-dependent cytotoxicity to HCEP cells in vitro, which is realized by inducing cell apoptosis that has been proven by cat corneal epithelial cells in vivo. Moreover, the clonidine-induced HCEP cell apoptosis is achieved through a death receptors-mediated, mitochondriadependent signaling pathway. Our findings provide new insights into the cytotoxicity and pro-apoptotic mechanisms of clonidine, and also references for its prospective therapeutic interventions in eye clinic.
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